IDiyas

For the Inventor, By the Inventor

Los Altos, CA, United States of America

Jürg Roland Pfister

USPTO Granted Patents = 12

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 106(Granted Patents)


Location History:

  • Los Altos, CA (US) (2005 - 2016)
  • Sunnyvale, CA (US) (2014 - 2016)
  • South San Francisco, CA (US) (2017 - 2019)

Company Filing History:

goldMedal4 out of 27 
 
Corsair Pharma, Inc.
 patents
silverMedal3 out of 5 
 
Theron Pharmaceuticals, Inc.
 patents
bronzeMedal2 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
4. 2 out of 50 
 
Aryx Therapeutics, Inc.
 patents
5. 1 out of 7 
 
Comentis, Inc.
 patents

Years Active: 2005-2019

Loading Chart...
12 patents (USPTO):Explore Patents
1. 10344012 - Treprostinil derivative compounds and methods of using same (2019-07-09),
2. 9845305 - Treprostinil derivative compounds and methods of using same (2017-12-19),
3. 9505737 - Treprostinil derivative compounds and methods of using same (2016-11-29),
4. 9371264 - Treprostinil derivative compounds and methods of using same (2016-06-21),
5. 9320731 - 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof (2016-04-26),
6. 8742131 - 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof (2014-06-03),
7. 8426611 - 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof (2013-04-23),
8. 8114891 - 4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof (2012-02-14),
9. 7265142 - Materials and methods for the treatment of hypertension and angina (2007-09-04),
10. 7091200 - Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists (2006-08-15),
11. 6900220 - Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists (2005-05-31),
12. 6864279 - Materials and methods for treating coagulation disorders (2005-03-08),

Title: Jürg Roland Pfister: Innovator in Pulmonary Hypertension Treatment

Introduction

Jürg Roland Pfister is a notable inventor based in Los Altos, California. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pulmonary hypertension. With a total of 12 patents to his name, Pfister's work has had a profound impact on medical therapies.

Latest Patents

Pfister's latest patents focus on treprostinil derivative compounds and methods of using them. These compounds, represented by specific formulae, include pro-drugs for treprostinil and prostacyclin analogs. They are designed for the treatment of pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH). The structures of these compounds can be adapted to suit particular applications, allowing for suitable treatment dosages. Additionally, transdermal applications can be utilized for effective delivery.

Career Highlights

Throughout his career, Pfister has worked with various companies, including Corsair Pharma, Inc. and Theron Pharmaceuticals, Inc. His expertise in pharmaceutical development has been instrumental in advancing treatments for serious health conditions.

Collaborations

Pfister has collaborated with notable professionals in his field, including Xiaoming Zhang and Meenakshi S Venkatraman. These partnerships have contributed to the innovative research and development of new therapeutic solutions.

Conclusion

Jürg Roland Pfister's contributions to the field of pulmonary hypertension treatment through his innovative patents and collaborations highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…